Oragenics Statistics

Total Valuation

Oragenics has a market cap or net worth of $5.69 million. The enterprise value is $3.75 million.

Market Cap	5.69M
Enterprise Value	3.75M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, after market close.

Earnings Date	Aug 12, 2024
Ex-Dividend Date	n/a

Share Statistics

Oragenics has 5.58 million shares outstanding. The number of shares has increased by 58.57% in one year.

Shares Outstanding	5.58M
Shares Change (YoY)	+58.57%
Shares Change (QoQ)	+35.00%
Owned by Insiders (%)	23.23%
Owned by Institutions (%)	10.38%
Float	4.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	275.94
Forward PS	n/a
PB Ratio	2.17
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	181.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.69, with a Debt / Equity ratio of 0.05.

Current Ratio	2.69
Quick Ratio	n/a
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-589.22

Financial Efficiency

Return on equity (ROE) is -414.60% and return on invested capital (ROIC) is -743.44%.

Return on Equity (ROE)	-414.60%
Return on Assets (ROA)	-326.00%
Return on Capital (ROIC)	-743.44%
Revenue Per Employee	$4,126
Profits Per Employee	-$4.05M
Employee Count	5
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.85% in the last 52 weeks. The beta is 0.50, so Oragenics's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	-73.85%
50-Day Moving Average	1.58
200-Day Moving Average	2.78
Relative Strength Index (RSI)	36.00
Average Volume (20 Days)	148,086

Short Selling Information

The latest short interest is 57,047, so 1.02% of the outstanding shares have been sold short.

Short Interest	57,047
Short Previous Month	58,982
Short % of Shares Out	1.02%
Short % of Float	1.41%
Short Ratio (days to cover)	1.05

Income Statement

In the last 12 months, Oragenics had revenue of $20,629 and -$20.26 million in losses. Loss per share was -$8.54.

Revenue	20,629
Gross Profit	20,629
Operating Income	-20.46M
Pretax Income	-20.26M
Net Income	-20.26M
EBITDA	-20.21M
EBIT	-20.23M
Loss Per Share	-$8.54

Full Income Statement

Balance Sheet

The company has $2.07 million in cash and $126,840 in debt, giving a net cash position of $1.95 million or $0.35 per share.

Cash & Cash Equivalents	2.07M
Total Debt	126,840
Net Cash	1.95M
Net Cash Per Share	$0.35
Equity (Book Value)	2.63M
Book Value Per Share	0.47
Working Capital	1.53M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.25 million and capital expenditures $63,716, giving a free cash flow of -$8.18 million.

Operating Cash Flow	-8.25M
Capital Expenditures	63,716
Free Cash Flow	-8.18M
FCF Per Share	-$2.34

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -99,181.69% and -98,219.66%.

Gross Margin	100.00%
Operating Margin	-99,181.69%
Pretax Margin	-98,219.66%
Profit Margin	-98,219.66%
EBITDA Margin	-97,975.26%
EBIT Margin	-98,053.25%
FCF Margin	-39,666.09%

Dividends & Yields

Oragenics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-58.57%
Shareholder Yield	-58.57%
Earnings Yield	-355.95%
FCF Yield	-143.75%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on January 23, 2023. It was a reverse split with a ratio of 1:60.

Last Split Date	Jan 23, 2023
Split Type	Reverse
Split Ratio	1:60

Scores

Oragenics has an Altman Z-Score of -97.27 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-97.27
Piotroski F-Score	1